Products

Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid)

    • Product Name: Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid)
    • Alias: SymCalmin
    • Einecs: 695-047-3
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    822400

    Product Name Dihydroavenanthramide D
    Synonym Hydroxyphenyl Propamidobenzoic Acid
    Chemical Formula C16H17NO4
    Molecular Weight 287.31 g/mol
    Appearance White to off-white powder
    Solubility Soluble in DMSO and ethanol
    Purity Typically ≥98%
    Cas Number 114810-45-2
    Origin Synthetic analog of avenanthramides (oat-derived)
    Function Anti-inflammatory and antioxidant agent
    Ph Stability Stable in pH 4-8
    Melting Point Approximately 152-155°C

    As an accredited Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, opaque HDPE bottle containing 25 grams of Dihydroavenanthramide D powder, secured with tamper-evident cap and printed safety label.
    Shipping Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid) is shipped in secure, airtight containers to protect from moisture and light. Typically dispatched via express courier under ambient conditions, each package includes labeling for chemical identification and handling instructions, complying with relevant regulations for safe and efficient delivery.
    Storage Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid) should be stored in a tightly sealed container, protected from light and moisture, at a temperature of 2–8°C (refrigerated). Store in a dry, well-ventilated area away from incompatible substances. Avoid exposure to heat or strong oxidizing agents. Proper storage ensures stability and prevents degradation of the compound.
    Application of Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid)

    Applications of Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid) in Industrial Manufacturing

    Dihydroavenanthramide D supports advanced industrial formulation in skin care, personal care, and specialty dermatological products. As the direct manufacturer, we supply this ingredient for sectors requiring high-purity and consistent quality for regulated downstream applications. Below, we present major application tracks focused on actual industry usage, providing specification-driven information for each use scenario across four key technical aspects.

    1. Dermatological Creams and Lotions

    This active compound plays a specialized role in professional skin barrier formulations for leave-on emulsions used by the personal healthcare sector. Medical-grade and cosmeceutical brands depend on standardized inclusion to meet anti-irritant requirements and support calming technology in chronic care and sensitive skin treatments. R&D and quality control teams select it for its proven functional profile under validated dosage ranges.

    Industry compliance standards

    • EU Cosmetics Regulation (EC) No 1223/2009
    • U.S. FDA OTC Monograph System (where applicable)
    • ISO 22716:2007 Good Manufacturing Practice (GMP) for cosmetics
    • Personal Care Products Council – Ingredient Safety Review

    Typical usage ratio

    • 0.01%–0.1% w/w; formulators often validate the minimum effective dose for anti-redness based on emulsion type and target demographic.

    Downstream process integration

    • Manufacturers dissolve the material in the water or oil phase during batch blending, typically before high-shear homogenization, ensuring dispersion homogeneity before adding temperature-sensitive actives.

    Final product types

    • Atopic skin barrier creams
    • Anti-itch and redness-relief lotions
    • Daily facial treatment moisturizers
    • Post-procedure recovery balms

    2. Leave-On Facial Serum Formulations

    Advanced facial serums rely on the anti-inflammatory and soothing potential of this molecule to differentiate premium skin repair lines and post-cosmetic treatment concentrates. Marketing claims often center on visible skin comfort and barrier function, supported by ingredient traceability and precision dosing to meet international commercialization requirements.

    Industry compliance standards

    • EU Cosmetics Regulation (EC) No 1223/2009
    • U.S. FDA Cosmetic Ingredient Review (CIR)
    • China GB/T 29665–2013 Cosmetics Hygiene Standard
    • ISO 16128 Natural and Organic Cosmetic Ingredients—Guidelines

    Typical usage ratio

    • 0.005%–0.08% w/w; creators fine-tune within this range to match product category (overnight serum, intensive ampoule), always confirming stability throughout shelf-life simulations.

    Downstream process integration

    • Technicians incorporate the compound during cool-down stages after emulsion or gel base formation, prior to fragrance addition or airless packaging, to maintain structural integrity of sensitive actives.

    Final product types

    • Calming repairing serums
    • Redness-neutralizing ampoules
    • Skin sensitivity relief vials
    • Intensive barrier-restoration gel creams

    3. After-Sun Soothing and Recovery Gels

    Sun-exposed skin products include this active to target immediate mitigation of irritation, reducing visible erythema and heat sensations. Industrial gel formulation teams appreciate its compatibility with aloe-based matrices and its performance in consumer patch tests, ensuring rapid claims validation for global launches.

    Industry compliance standards

    • EU Cosmetics Regulation (EC) No 1223/2009
    • U.S. FDA Cosmetics Regulatory Framework (adverse event reporting)
    • Japan MHLW Standards for Cosmetics
    • ASEAN Cosmetic Directive (ACD)

    Typical usage ratio

    • 0.02%–0.06% w/w; process engineers adjust concentration based on aloe content and gel viscosity for targeted consumer markets (Europe, US, APAC).

    Downstream process integration

    • The functional ingredient enters at the aqueous mixing phase, pre-neutralization, supporting uniform distribution and consistent anti-irritant response in finished gels and topical sprays.

    Final product types

    • After-sun cooling gels
    • Spray-on post-sun exposure treatments
    • Burn and redness-relief sticks
    • Pain-relief hydrogel sheets

    4. Scalp Care and Anti-Itch Shampoo Formulation

    Manufacturers of specialized scalp treatment systems add this ingredient to address consumer demand for sensitive scalp and anti-irritant claims. Laboratory formulations confirm synergistic mildness with cleansing surfactants and botanical actives, meeting market trends for non-pharmaceutical itch relief solutions that comply with stability, rinse-off efficacy, and sensory expectations.

    Industry compliance standards

    • EU Cosmetics Regulation (EC) No 1223/2009
    • Cosmetic Ingredient Review (CIR) Expert Panel, US
    • ISO 17516:2014 Microbiological Quality of Cosmetics
    • Brazil ANVISA RDC No. 7/2015 Hair Care Product Safety

    Typical usage ratio

    • 0.01%–0.05% w/w; in high-surfactant bases, developers may increase up to 0.08% for targeted relief while validating rinse-off efficiency in QC protocols.

    Downstream process integration

    • Blending occurs during the post-emulsification phase of shampoo or scalp serum bases, avoiding elevated temperatures and minimizing interaction with cationic thickeners for clear labeling and reproducible effects.

    Final product types

    • Soothing scalp shampoos
    • No-rinse scalp tonics
    • Leave-in anti-itch scalp serums
    • Medicated scalp gel cleansers

    5. Medical Device Skin Contact Gels

    Medical device manufacturers in wound care and dermatological diagnostics introduce this compound into specialty contact gels for its role in patient comfort and biocompatibility. The focus for procurement teams is on traceable batch quality data and alignment with device-specific technical files under regulated regimes.

    Industry compliance standards

    • EU Medical Device Regulation (MDR) 2017/745 Class I/IIa (where relevant for skin-contact accessories)
    • U.S. FDA 21 CFR Part 820 (Quality System Regulation for Medical Devices)
    • ISO 10993-1:2018 Biocompatibility Evaluation
    • ICH Q7 GMP for Active Pharmaceutical Ingredients (if used in combination product contexts)

    Typical usage ratio

    • 0.01%–0.04% w/w; formulation teams determine the inclusion rate by testing the gel base and expected patient tolerance in controlled trials.

    Downstream process integration

    • Production adds the ingredient to the base gel or hydrogel blend prior to autoclave sterilization or aseptic filling of device accessories, ensuring preserved activity and functional stability post-sterilization.

    Final product types

    • Wound interface hydrogels for dressings
    • Electroconductive contact gels
    • Skin diagnostic patch media
    • Adhesive hydrogel pads for medical devices

    Free Quote

    Competitive Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid) prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Dihydroavenanthramide D (Hydroxyphenyl Propamidobenzoic Acid)

    Real Experience Behind Producing Dihydroavenanthramide D

    Turning out batches of Dihydroavenanthramide D is nothing like pushing out a standard additive. We’ve spent years in the chemical manufacturing business examining every part of the process, from molecular synthesis to practical, everyday formulation. This shows up in our approach to Hydroxyphenyl Propamidobenzoic Acid, a specialty molecule born from a blend of precision chemistry and findings in oat science. This ingredient draws attention in modern skincare labs, not because it’s trendy, but because of its connection to what actually works against irritation and redness.

    Those who work with raw oat derivatives already know about avenanthramides. These natural molecules stick out due to their role in calming the skin. Dihydroavenanthramide D presents itself as a laboratory-crafted analog, tailored not from nostalgic reference to old folk remedies, but from detailed molecular studies. Years back, our team sifted through patents and journals, chasing after a method to consistently replicate oat-like benefits without relying on old plant extraction tricks. Eventually, this led to the synthetic form, which not only mimics natural avenanthramides but goes a step further by offering better purity and higher stability.

    Consistency, Purity, and Practical Performance

    Making Dihydroavenanthramide D for the real world comes with its challenges. One misstep in purification, and you get yellow residues or impurities that show up in the final formulation. Our batches run through multi-stage chromatography and crystallization, monitored carefully for color, solubility, and composition. Skincare chemists who have struggled with inconsistent natural extracts can relate—no surprises crop up once our product enters their mixing tanks. Purity always hovers above lab-confirmed thresholds, so stability tests show actual results instead of best-case wishes.

    Each lot passes HPLC analysis. Typical specification standards for our Dihydroavenanthramide D go above 98 percent purity. As an active for anti-irritant creams, we focus on maintaining a consistent melting point in the 170–176°C range. Our process forgoes the traces of methyl and ethyl derivatives that pop up in some imported alternatives. Once we nail down parameters, every kilogram looks and behaves the same, from the first scoop to the bottom of the drum. Our production lines keep solvents out of the final product, and we monitor for heavy metals below 10 ppm.

    Benefits in Practice: Why Chemists Favor Dihydroavenanthramide D

    Adding Dihydroavenanthramide D to skin lotions or topical soothing gels brings predictable benefits. After years spent testing prototypes, our colleagues report the same outcome: lower visible redness and a reduction in the itching often reported with retinols and strong surfactants. The material doesn’t just sit inactive; assays with reconstructed skin models highlight a tangible reduction in markers like IL-8, which act as signposts for skin irritation.

    This ingredient dissolves in most common emulsion systems. Chemists mixing it into water-based creams or glycerin-rich serums find it remains clear and doesn’t separate. Some try incorporating it directly into hot-phase oil dispersions, but our firsthand experience says it works best when dissolved in propylene glycol or ethanol before blending. Application at 0.2–0.5% creates results that show up within a reasonable time frame: users speak of calmer skin after two to three days of use.

    We draw our confidence from extended shelf-life tests. Dihydroavenanthramide D resists hydrolysis far better than natural extracts. This means the calming properties survive longer, a crucial factor for formulators tired of rewriting expiration dates. We keep samples running through accelerated stability ovens for months because customers want assurance a cream won’t turn yellow or lose strength after a season in storage.

    Comparing to Other Bases — Synthetic Versus Plant-Derived

    A constant debate brews around natural versus synthetic ingredients. Many assume plant-based automatically means better or safer, but those of us overseeing full-scale manufacturing notice the limits. Naturally extracted avenanthramides often arrive with a cocktail of sugars, proteins, and trace elements. These cause lot-to-lot variations and complicate solubility in finished products. We routinely get calls from formulators struggling to mask earthy odors and shades of brown that come with oat extracts—not issues seen with our synthetic Dihydroavenanthramide D.

    Comparing efficacy, the synthetic form’s higher purity pulls ahead. A clean molecule interacts more reliably with skin targets. Randomized clinical studies demonstrate reduced redness in challenged skin without the risks of allergenic plant proteins. Allergenicity drops virtually to zero, thanks to the absence of oat dust, gluten, or microbial residues. Since our synthesis doesn’t rely on farming or seasonal harvests, we offer the same material winter or summer, under pandemic or drought.

    Environmental accountability matters in chemical manufacturing, and synthetic Dihydroavenanthramide D places less burden on land. Growing oats for extracts devours water and acreage, and brings pesticide residues into play. Our process tightens resource use to small batch reactors, efficient waste management, and solvent recovery. Years spent auditing environmental outputs in the plant prompted us to swap out older purification solvents for less hazardous options.

    Formulation Advice from Our Own Lab

    Many cosmetic manufacturers have walked their first development projects through our pilot lab. During these visits, questions always land in the same areas: solubility, compatibility, and odor. In our experience, Dihydroavenanthramide D disappears into clear surfactant bases with gentle stirring and doesn’t break emulsion, even in amphoteric systems. It won’t interact negatively with Vitamins C or E, which makes it easy to pair with antioxidant claims.

    Some brands ask about mixing with acids or exfoliants. Our chemists tested these combinations in low-pH environments, and find Dihydroavenanthramide D maintains molecular stability even below pH 5. Glycolic and lactic acid blends remain stable, so long as water content and preservative selection all line up. For those working with organic certification, we confirm that our process leaves nothing behind that would interfere with most eco-label requirements, so the ingredient fits in a broad swath of ‘clean beauty’ ranges.

    Routine batch sampling in our application room revealed something important for scale production. Even if teams slip and add the material later in the process, it still disperses evenly. This feature matters for fast-paced lines, where mistakes strain timelines and budgets. Concerns about clumping or sediment are misplaced; we’ve never needed high-shear mixers thanks to its favorable flow properties.

    Trends Driving Use in Tomorrow’s Products

    Demand for true skin-calming actives shot up in recent years, driven by the visible effects of pollution and the rising popularity of exfoliating acids. We’ve kept pace by fine-tuning lots of Dihydroavenanthramide D toward gentler use, so the sharp-edged sting that sometimes trails behind synthetic additives never turns up. Customer feedback trends show not only less visible irritation but also comments about light sensation and absence of sticky feel on the skin.

    Brands in Asia and North America approach us for projects that target post-laser care and children’s eczema. Pediatricians look for ingredients that lower the risk of immune reactions, and Dihydroavenanthramide D lines up here impressively. Allergenicity studies in our partnered clinics found zero positive patch test reactions in healthy or atopic patients. The absence of fragrance and color means formula creators avoid the pitfalls found in botanical-based soothers, securing clean-label status without the risks lurking in complex plant extracts.

    Formulators working on hybrid SPF or barrier creams catch on to the use of Dihydroavenanthramide D as a sidekick to zinc oxide or chemical sunscreens. Its protective profile helps offset the dryness linked to mineral UV blockers, and prevents the heat-induced prickling that sometimes follows a day outdoors. Testing in routine field studies demonstrated rapid calming after application, even at the end of a hot, windy day.

    Long-Term Reliability for Commercial Production

    Years in the chemical manufacturing field teach us to respect the routines of brands and contract manufacturers. Production planners do not appreciate last-minute surprises or the need to tinker with processes on the fly. Early on, many small brands came to us with production logs detailing lost batches due to supplier inconsistency. Since transitioning to our synthetic Dihydroavenanthramide D, those production holds all but disappeared. With each tightly controlled batch, we give formulators the certainty that their end product will not shift in color, viscosity, or appearance from run to run.

    Documented shelf-life stretches up to three years in typical storage—unopened, tightly sealed, out of direct sun. Formula developers gain back lost time, since the material doesn’t degrade to off-smelling byproducts or develop visible sediment in six months like some plant extracts. We back every delivery with data from both temperature cycling and long-term storage studies. As manufacturers, we’ve seen this confidence shift entire lines from reactive mode to stable, long-planned scale-up.

    Supply reliability proved crucial during volatile times—whether from sudden lockdowns or shipping delays. With self-contained production in a single site, we’ve ridden out raw material shortages and border restrictions that left others relying on imports scrambling. Our team lines up multiple rounds of quality checks at each stage: raw material, intermediate, and finished product, all carried out by trained chemists with skin in the game.

    Future Proofing with Transparent Production

    Clients increasingly ask for ingredient traceability. We have responded by documenting every step of our synthetic process, so product developers receive certificates showing the absence of residual solvents or known allergens. We leaned on workflow automation to digitize lot records, providing real-time updates on quality parameters. No matter the audit—routine inspection or spot-check from major brand compliance officers—we can open the books and pull out precise data on origin, purity, and manufacturing date.

    Feedback loops with customers influence our workflow. Once, a formulator flagged a temporary spike in fine particulate count during a scale-up. Instead of shifting blame, our chemical engineers tracked the root cause to a minor valve issue, fixed it the next morning, and validated the next batches in triplicate to exceed regular benchmarks. This attention to detail comes directly from working in-house, not brokering someone else’s product.

    Being a true manufacturer means taking responsibility for both the promise and the follow-through. That means recycling solvent streams, monitoring effluents for downstream impacts, and always offering transparent dialogue when technical questions arise. The direct connection with buyers and users informs how we continue refining each synthesis batch of Dihydroavenanthramide D for the next generation of skincare.

    Conclusion: Where Dihydroavenanthramide D Fits Tomorrow

    As chemical manufacturers, we've watched ingredient fads come and go. Dihydroavenanthramide D remains a mainstay not due to clever marketing or internet trends, but because results reach skin rapidly, without the baggage attached to variable natural extracts. Our investment in production technology, strict adherence to purity, and willingness to tackle logistical challenges head on support not just today’s formulas, but also those shaping the future of skin care. Whether serving as the active heart of post-procedural balms, daily creams, sun care, or children's lotions, our Dihydroavenanthramide D answers to practical real-world needs, no matter how the direction of the industry shifts.

    Top